nach oben

Erschienen in:

01.07.2010 | Original Paper

Effect of erythromycin A and its new derivative EM201 on type I collagen production by cultured dermal fibroblasts

verfasst von: Hiromi Namikawa, Toshiaki Sunazuka, Yohei Kitamura, Toshihiro Suzuki, Yoichiro Hamasaki, Soji Yamazaki, Satoshi Omura, Atsushi Hatamochi

Erschienen in: Archives of Dermatological Research | Ausgabe 5/2010

Einloggen, um Zugang zu erhalten

Abstract

Thinning of the dermis is the principal histological change in atrophic skin disorders and aged skin. It is caused due to a decreased amount of collagen in the dermis. Macrolides have been reported to exert various pharmacological activities, including anti-inflammatory activity, tumor angiogenesis inhibition and growth inhibition of fibroblasts, in addition to antimicrobial activity. In this study, we investigated the effects of erythromycin A (EMA) and its new derivative EM201 on type I collagen production by cultured dermal fibroblasts. Dermal fibroblasts were cultured with 10⁻⁹ M-10⁻⁵ M EMA or EM201, and collagen production was measured by incubation with radioactive proline, SDS-polyacrylamide gel electrophoresis and fluorography. mRNA levels were measured by Northern blots analysis, and to investigate transcriptional levels luciferase assays were also performed. The results showed that both EMA and EM201 increased collagen production and type I collagen mRNA level (to a maximum of 200% with EMA and 250% with EM201) in a dose-dependent manner in cultured dermal fibroblasts. Transcription of the type I collagen gene was also increased by both macrolides. These results suggest that EMA and EM201 have the potential to improve the thinning of the dermis in atrophic skin disorders and aged skin.

Aoki D, Ueno S, Kubo F, Oyama T, Sakuta T, Matsushita K, Maruyama I, Aikou T (2005) Roxithromycin inhibits angiogenesis of human hepatoma cells in vivo by suppressing VEGF production. Anticancer Res 25:133–138PubMed

Arcari P, Martinelli R, Salvatore F (1984) The complete sequence of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase: evidence for multiple mRNA species. Nucleic Acids Res 12:9179–9189CrossRefPubMed

Bembenek ME, Willis DH Jr, Liberti JP (1982) The effect of insulin on collagen production in isolated chondrosarcoma chondrocytes. Biochem Biophys Res Commun 106:338–345CrossRefPubMed

Chu ML, Myers JC, Bernard MP, Ding JF, Ramirez F (1982) Cloning and characterization of five overlapping cDNAs specific for the human pro alpha 1(I) collagen chain. Nucleic Acids Res 10:5925–5934CrossRefPubMed

Czaja MJ, Weiner FR, Eghbali M, Giambrone MA, Eghbali M, Zern MA (1987) Differential effects of gamma interferon on collagen and fibronectin gene expression. J Biol Chem 262:13348–13351PubMed

Duncan MR, Berman B (1991) Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibrolasts by recombinant human interleukin 6. J Invest Dermatol 97:686–692CrossRefPubMed

Falanga V, Martin TA, Takagi H, Kirsner RS, Helfman T, Pardes J, Ochoa MS (1993) Low oxygen tension increases mRNA levels of alpha 1 (I) procollagen in human dermal fibroblasts. J Cell Physiol 157:408–412CrossRefPubMed

Fleischmajer R, Perlish JS, Krieg T, Timple R (1981) Variability in collagen and fibronectin synthesis by scleroderma fibroblasts in primary culture. J Invest Dermatol 76:400–403CrossRefPubMed

Geesin JC, Darr D, Kaufman R, Murad S, Pinnell SR (1988) Ascorbic acid specifically increases type I and type III procollagen messenger RNA levels in human skin fibroblast. J Invest Dermatol 90:420–424CrossRefPubMed

10.

Hamalainen L, Oikarinen J, Kivirikko KI (1985) Synthesis and degradation of type I procollagen mRNAs in cultured human skin fibroblasts and the effect of cortisol. J Biol Chem 260:720–725PubMed

11.

Hata R, Kurata S, Shinkai H (1988) Existence of malfunctioning pro alpha2(I) collagen genes in a patient with a pro alpha2(II)-chain-defective variant of Ehlers–Danlos syndrome. Eur J Biochem 174:231–237CrossRefPubMed

12.

Hatamochi A, Aumailley M, Mauch C, Chu ML, Timpl R, Krieg T (1989) Reguration of collagen VI expression in fibroblasts: effect of cell density, cell–matrix interactions, and chemical transformation. J Biol Chem 264:3494–3499PubMed

13.

Hatamochi A, Arakawa M, Takeda K, Ueki H (1994) Activation of fibroblast proliferation by Werner’s syndrome fibroblast-conditioned medium. J Dermatol Sci 7:210–216CrossRefPubMed

14.

Hatamochi A, Kuroda K, Shinkai H, Kohma H, Oishi Y, Inoue S (1998) Regulation of matrix metalloproteinase (MMP) expression in cutis laxa fibroblasts: upregulation of MMP-1, MMP-3 and MMP-9 genes but not of the MMP-2 gene. Br J Dermatol 38:757–762CrossRef

15.

Hildebran JN, Absher M, Low RB (1983) Altered rates of collagen synthesis in in vitro aged human lung fibroblasts. In Vitro 19:307–314CrossRefPubMed

16.

Ianaro A, Ialenti A, Maffia P, Sautebin L, Rombola L, Carnuccio R, Iuvone T, D’Acquisto F, Di Rosa M (2000) Anti-inflammatory activity of macrolide antibiotics. J Pharmacol Exp Ther 292:156–163PubMed

17.

Ikeda H, Sunazuka T, Suzuki H, Hamasaki Y, Yamazaki S, Omura S, Hatamochi A (2008) EM703, the new derivate oferythromycin, inhibits transcription of type I collagen in normal and scleroderma fibroblast. J Dermatol Sci 49:195–205CrossRefPubMed

18.

Jimenez SA, Hitraya E, Varga J (1996) Pathogenesis of scleroderma: collagen. Rheum Dis Clin North Am 22:647–674CrossRefPubMed

19.

Kitamura Y, Namikawa H, Hayashi S, Yoshida T, Suzuki T, Hamasaki Y, Yamazaki S, Hatamochi A (2009) Effects of UVA irradiation following treatment with 8-methoxypsoralen on type I and type III collagen synthesis in normal and scleroderma fibroblast cultures. Arch Dermatol Res (in press)

20.

Kobayashi M, Shimauchi T, Hino R, Tokura Y (2004) Roxithromycin downmodulates Th2 chemokine production by keratinocytes and chemokine receptor expression on Th2 cells: its dual inhibitory effects on the ligands and the receptors. Cell Immunol 228:27–33CrossRefPubMed

21.

Kurata S, Hata R (1991) Epidermal growth factor inhibits transcription of type I collagen genes and production of type I collagen in cultured human skin fibroblasts in the presence and absence of l-ascorbic acid 2-phosphate, a long-acting vitamin C derivative. J Biol Chem 266:9997–10003PubMed

22.

Li YJ, Azuma A, Usuki J, Abe S, Matsuda K, Sunazuka T, Shimizu T, Hirata Y, Inagaki H, Kawada T, Takahashi S, Kudoh S, Omura S (2006) EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-β signaling in lung fibroblasts. Respir Res 7:1–13CrossRef

23.

Mori K, Hatamochi A, Ueki H, Olsen A, Jimenez SA (1996) The transcription of human α1(I) procollagen gene (COL 1 A 1) is suppressed by tumor necrosis factor-α through proximal short promoter elements: evidence for suppression mechanisms mediated by two nuclear factor binding sites. Biochem J 319:811–816PubMed

24.

Nonaka M, Pawankar R, Tomiyama S, Yagi T (1999) A macrolide antibiotic roxithromycin inhibits the growth of nasal polyp fibroblasts. Am J Rhinol 13:267–272CrossRefPubMed

25.

Raghow R, Postlethwaite AE, Keski-Oja J, Moses HL, Kang AH (1987) Transforming growth factor-beta increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibrobrasts. J Clin Invest 79:1285–1288CrossRefPubMed

26.

Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH et al (1986) Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83:4167–4171CrossRefPubMed

27.

Saitta B, Gaidarova S, Cicchillitti L, Jimenez SA (2000) CCAAT binding transcription factor binds and regulates human COL1A1 promoter activity in human dermal fibroblasts: demonstration of increased binding in systemic sclerosis fibroblasts. Arthritis Rheum 43:2219–2229CrossRefPubMed

28.

Sandmeyer S, Gallis B, Bornstein P (1981) Coordinate transcriptional regulation of type I procollagen genes by Rous sarcoma virus. J Biol Chem 256:5022–5028PubMed

29.

Sato M, Shegogue D, Hatamochi A, Yamazaki S, Trojanowska M (2004) Lysophosphatidic acid inhibits TGF-beta-mediated stimulation of type I collagen mRNA stability via an ERK-dependent pathway in dermal fibroblasts. Matrix Biol 23:353–361CrossRefPubMed

30.

Shuster S, Black MM, Mcvitie E (1975) The influence of age and sex on skin thickness, skin collagen and density. Br J Dermatol 93:639–642CrossRefPubMed

31.

Solis-Herruzo JA, Brenner DA, Chojkier M (1988) Tumor necrosis factor alpha: inhibits collagen gene transcription and collagen systhesis in cultured human fibroblasts. J Biol Chem 263:5841–5845PubMed

32.

Yatsunami J, Tsuruta N, Hara N, Hayashi S (1998) Inhibition of tumor angiogenesis by roxithromycin, a 14-membered ring macrolide antibiotic. Cancer Lett 131:137–143CrossRefPubMed

33.

Yatsunami J, Fukuno Y, Nagata M, Tominaga M, Aoki S, Tsuruta N, Kawashima M, Taniguchi S, Hayashi S (1999) Antiangiogenic and antitumor effects of 14-membered ring macrolides on mouse B16 melanoma cells. Clin Exp Metastasis 17:361–367PubMed

34.

Yoshida K, Sunazuka T, Nagai K, Sugawara A, Cho A, Nagamitsu T, Harigaya Y, Otoguro K, Akagawa (2005) Macrolides with promotive activity of monocyte to macrophage differentiation. J Antibiot 58:79–81CrossRefPubMed

Titel: Effect of erythromycin A and its new derivative EM201 on type I collagen production by cultured dermal fibroblasts
verfasst von: Hiromi Namikawa
Toshiaki Sunazuka
Yohei Kitamura
Toshihiro Suzuki
Yoichiro Hamasaki
Soji Yamazaki
Satoshi Omura
Atsushi Hatamochi
Publikationsdatum: 01.07.2010
Verlag: Springer-Verlag
Erschienen in: Archives of Dermatological Research / Ausgabe 5/2010
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI: https://doi.org/10.1007/s00403-009-0977-z

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Dermatologie

22.04.2024 | DGIM 2024 | Nachrichten

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Effect of erythromycin A and its new derivative EM201 on type I collagen production by cultured dermal fibroblasts

Abstract

Leitlinien kompakt für die Dermatologie

Neu im Fachgebiet Dermatologie

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Update Dermatologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2010

A minimally invasive human in vivo cutaneous wound model for the evaluation of innate skin reactivity and healing status

A novel point mutation at donor splice-site in intron 42 of type III collagen gene resulting in the inclusion of 30 nucleotides into the mature mRNA in a case of vascular type of Ehlers–Danlos syndrome

Clearance of experimental cutaneous Staphylococcus aureus infections in mice

A novel human skin chamber model to study wound infection ex vivo

Capparis spinosa protects against oxidative stress in systemic sclerosis dermal fibroblasts

Genetics of keloid scarring

Leitlinien kompakt für die Dermatologie

Neu im Fachgebiet Dermatologie

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Update Dermatologie